Compensatory activation of sterol regulatory element-binding protein 1c (SREBP-1c) sustains de novo lipogenesis despite insulin resistance [55], while impaired adipocyte insulin response exacerbates dyslipidemia through reduced FFA uptake and TG synthesis [56,57,58]. The gene discussed is INS; the disease is metabolic syndrome.